{
  "retracted": false,
  "timestamp": 1515542400000,
  "updates": [
    {
      "timestamp": 1585509068453,
      "identifier": {
        "doi": "10.1038/s41467-017-02205-9"
      },
      "type": "correction"
    }
  ],
  "identifier": {
    "doi": "10.1038/s41467-017-01385-8"
  },
  "publisher": "Springer Science and Business Media LLC",
  "title": "Author Correction: Re-designing Interleukin-12 to enhance its safety and potential as an anti-tumor immunotherapeutic agent"
}
